IP 179 (Metformin ER 750 mg)
Pill imprint IP 179 has been identified as Metformin hydrochloride extended release 750 mg.
Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- IP 179
- Strength:
- 750 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Amneal Pharmaceuticals
- National Drug Code (NDC):
- 53746-0179
| NDC Code | Manufacturer / Repackager |
|---|---|
| 42291-0611 | AvKare, Inc. |
Note: Inactive ingredients may vary.
More about metformin
Consumer resources
- Other brands: Glucophage, Glumetza, Glucophage XR, Fortamet, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
